Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Equity (2017 - 2025)

Historic Return on Equity for cbdMD (YCBD) over the last 9 years, with Q4 2025 value amounting to 0.29%.

  • cbdMD's Return on Equity rose 11500.0% to 0.29% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.29%, marking a year-over-year increase of 11500.0%. This contributed to the annual value of 0.44% for FY2025, which is 2300.0% up from last year.
  • As of Q4 2025, cbdMD's Return on Equity stood at 0.29%, which was up 11500.0% from 0.31% recorded in Q3 2025.
  • cbdMD's Return on Equity's 5-year high stood at 0.0% during Q1 2021, with a 5-year trough of 6.35% in Q2 2024.
  • In the last 5 years, cbdMD's Return on Equity had a median value of 1.1% in 2022 and averaged 1.47%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -55100bps in 2024, then surged by 59100bps in 2025.
  • cbdMD's Return on Equity (Quarter) stood at 0.2% in 2021, then tumbled by -826bps to 1.89% in 2022, then plummeted by -31bps to 2.49% in 2023, then surged by 42bps to 1.44% in 2024, then skyrocketed by 80bps to 0.29% in 2025.
  • Its Return on Equity stands at 0.29% for Q4 2025, versus 0.31% for Q3 2025 and 0.45% for Q2 2025.